Probably because of the anti-apoptotic and anti-inflammatory effects, G-CSF has also been used to treat nonhematopoietic targets including cerebral ischemia [44], spinal cord ischemia [45], infarct heart [46], and end stage liver disease [47]. The gene discussed is CSF3; the disease is spinal cord ischemia.